Alendronate: a new bisphosphonate for the treatment of osteoporosis.
Alendronate is a drug with considerable potential. It is likely to work best in elderly patients with moderate to severe osteoporosis. Long-term studies and comparison with other therapeutic agents are needed before its exact role is established.
Keen
R W
RW
Rheumatology Department, St Thomas' Hospital, London.
Spector
T D
TD
D019386:Alendronate; D015519:Bone Density / Q000187:drug effects*; D004164:Diphosphonates / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*
D004164:Diphosphonates; D019386:Alendronate